Secondary Logo

Journal Logo

May 2004 - Volume 11 - Issue 3
pp: 129-200

Is There Any Advantage to Using Levalbuterol in the Treatment of Asthma?

Weinberger, Miles

Clinical Pulmonary Medicine. 11(3):129-134, May 2004.


Pneumocystis Pneumonia: Controversies

Barry, S M.; Johnson, M A.

Clinical Pulmonary Medicine. 11(3):135-142, May 2004.

Genetic Effects on Sepsis and Pneumonia

Wunderink, Richard G.; Waterer, Grant W.

Clinical Pulmonary Medicine. 11(3):143-153, May 2004.


New Therapies for Sarcoidosis

Baughman, Robert P.; Lower, Elyse E.

Clinical Pulmonary Medicine. 11(3):154-160, May 2004.


Therapy for Stage IIIA, IIIB and IV Non–Small Cell Lung Cancer

Kim, Tracy E.; Murren, John R.

Clinical Pulmonary Medicine. 11(3):161-174, May 2004.


Noninvasive Mechanical Ventilation in Immunocompromised Patients

Hilbert, Gilles; Gruson, Didier; Vargas, Fréderic

Clinical Pulmonary Medicine. 11(3):175-182, May 2004.

Nutrition and Oxidants in the Critically Ill Patient

Richards, G A.

Clinical Pulmonary Medicine. 11(3):183-187, May 2004.


Bronchoscopic Myths and Legends

Killeen, David; Chin, Robert; Conforti, John

Clinical Pulmonary Medicine. 11(3):188-190, May 2004.



Nonresolving Pneumonia in an Otherwise Healthy Patient

Gotway, Michael B.; Leung, Jessica W. T.; Dawn, Samuel K.; More

Clinical Pulmonary Medicine. 11(3):198-200, May 2004.